TIM-3/Galectin-9 and CD160 expression in salivary adenoid cystic carcinoma

Oral Dis. 2024 May;30(4):2262-2274. doi: 10.1111/odi.14666. Epub 2023 Jul 17.

Abstract

Objective: Investigating T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), Galectin 9 (Gal-9), CD160 expression and tumor-infiltrating lymphocytes (TILs) and correlation with clinicopathological characteristics of salivary adenoid cystic carcinoma (SACC).

Methods: Sixty cases of SACC were detected by immunohistochemical staining to evaluate TIM-3, Gal-9, and CD160 expression and analyze the correlation between TIM-3, Gal-9, CD160 expression and clinicopathologic features by rank-sum test. The association of TILs with TIM-3, Gal-9, and CD160 expression in SACC stromal was done by Chi-square test.

Results: TIM-3 and CD160 overexpression were correlated with recurrence of SACC (p = 0.029, p = 0.007, respectively). High Gal-9 expression was correlated with pathological classification (p = 0.018). The average percentage of TILs was 18.2% in SACC and most of TILs were more likely to occur in minor salivary glands (p = 0.038). Pairwise positive correlations were observed between the expression of TIM-3, Gal-9, and CD160 in tumor cells as well as in TILs, respectively.

Conclusion: Low density of TILs was characteristic of the SACC microenvironment, with upregulation of TIM-3, Gal-9, and CD160 all occurring. However, TIM-3, Gal-9, and CD160 expression in the stromal dependent on the number of TILs represent potential therapeutic targets in SACC.

Keywords: CD160; Gal‐9; TIM‐3; immunohistochemical; salivary adenoid cystic carcinoma; tumor‐infiltrating lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antigens, CD* / metabolism
  • Carcinoma, Adenoid Cystic* / metabolism
  • Carcinoma, Adenoid Cystic* / pathology
  • Female
  • GPI-Linked Proteins / analysis
  • GPI-Linked Proteins / metabolism
  • Galectins* / analysis
  • Galectins* / metabolism
  • Hepatitis A Virus Cellular Receptor 2* / analysis
  • Hepatitis A Virus Cellular Receptor 2* / metabolism
  • Humans
  • Lymphocytes, Tumor-Infiltrating*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Receptors, Immunologic
  • Salivary Gland Neoplasms* / metabolism
  • Salivary Gland Neoplasms* / pathology

Substances

  • Hepatitis A Virus Cellular Receptor 2
  • HAVCR2 protein, human
  • LGALS9 protein, human
  • Antigens, CD
  • Galectins
  • CD160 protein, human
  • GPI-Linked Proteins
  • Receptors, Immunologic